All News

A review of hospitalized patients with COVID-19 links female sex, severe acute illness, and intensive care unit admission to higher odds of long COVID.

Adults with type 1 diabetes who used Omnipod 5 Automated Insulin Delivery System maintained significant improvements in time in range and hemoglobin A1C.

A Bayesian meta-analysis finds patients regain half their treatment-associated weight loss within about 7.5 months of stopping semaglutide or tirzepatide.

AD109 significantly reduces breathing interruptions in adults with obstructive sleep apnea who could not tolerate or had refused CPAP therapy.

A population-level analysis finds that age, comorbidity burden, and long-term care residence continue to drive severe outcomes.

The combination outperformed ixekizumab alone on skin, joint, and weight outcomes through 52 weeks.

Data shows that those who stayed on tirzepatide had monthly health care costs well below those of untreated adults.

For patients living with ASCVD, researchers find the optimal approach for ensuring medication adherence within patients’ statin regimens.

Data show adults who received the recombinant shingles vaccine had a lower cardiovascular burden than those who received the discontinued live vaccine.

New recommendations from the American Academy of Neurology and American Headache Society give providers clearer criteria for preventive migraine therapy.

Presenting what they believe are the problems and solutions, PCMA CEO David Marin and NCPA CEO Douglas Hoey, RPh, discuss the US drug pricing dilemma.

The 4 key organizations regularly focusing on respiratory virus season released updated vaccine recommendations for 2026-2027.

As data reframes vaccines as a lifelong tool, pharmacists are becoming the access point that keeps patients up to date at every stage of life.

The American Pharmacists Association, Canadian Pharmacists Association, and International Pharmaceutical Federation release plans for pharmacists’ primary care integration.

JD Power releases its US Pharmacy Digital Experience Study, highlighting the growing importance of digital solutions in pharmacy practice and business.

In part 2, Scott Stoll and Kenzie Hohman, PharmD, explain their respective advocacy efforts, highlighting the sheer range of a profession fighting for change.

Live attenuated influenza vaccine increased pneumococcal density in vaccinated children, raising odds of pneumococcal infection among household contacts.

The federal government is actively looking to enhance its evolving approach toward US childhood vaccine recommendations.

The first new US sunscreen active ingredient in years is reaching shelves through dsm-firmenich's Parsol Shield and Ultra Violette's new SPF launch.

Data show starting antivirals within 48 hours of symptom onset sharply lowers pediatric hospitalization risk.

The approval gives pharmacists a new nonTNF biologic option across both major forms of pediatric inflammatory bowel disease.

With previous approvals for weight loss and sleep apnea, tirzepatide is opening doors to a healthier well-being for patients living with type 2 diabetes.

Pfizer and BioNTech, Moderna, Sanofi, and Takeda received FDA approval for updated 2026-2027 COVID-19 vaccines reformulated to target the XFG variant.

New consensus confirms that chronic obstructive pulmonary disease, asthma, bronchiectasis, and lung cancer are indications for pneumococcal vaccination.

This fall’s event will focus on the expanding role of pharmacists in providing patient care with clinical value, prevention, and more.

Researchers identify the resources and opportunities available for community pharmacies to incorporate climate-conscious health care practices.

A study links dormant virus reactivation during COVID-19 hospitalization to inflammation-driven immune changes and long COVID disability.

Focusing on serotype distribution, resistance trends, and vaccination impact, researchers analyze invasive pneumococcal disease burden.